Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
Loading
Pre-Tax Margin Over TimeExpanding
Percentile Rank79
3Y CAGR-6.7%
5Y CAGR-5.2%
Year-over-Year Change
Pre-tax income as a percentage of revenue
3Y CAGR
-6.7%/yr
vs +24.5%/yr prior
5Y CAGR
-5.2%/yr
Consistent
Acceleration
-31.3pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 38.45% | +1605.3% |
| 2024 | 2.25% | -94.9% |
| 2023 | 44.38% | -6.4% |
| 2022 | 47.39% | +31.5% |
| 2021 | 36.05% | -28.2% |
| 2020 | 50.23% | +49.9% |
| 2019 | 33.51% | +70.1% |
| 2018 | 19.70% | +3224.2% |
| 2017 | -0.63% | +84.1% |
| 2016 | -3.96% | - |